ANTONENKO, S.V.; TELEGEEV, G.D. Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells. Experimental Oncology, [S. l.], v. 42, n. 2, p. 109–114, 2023. DOI: 10.32471/exp-oncology.2312-8852.vol-42-no-2.14533. Disponível em: https://exp-oncology.com.ua/index.php/Exp/article/view/2020-2-10. Acesso em: 27 jun. 2026.